Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

The Medicines Company

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of The Medicines Company's 2013 cardiovasular sales performance.

The Medicines Company

FDA gives the nod to TMC's antiplatelet drug

FDA gives the nod to TMC's antiplatelet drug The Medicines Company (TMC) has finally won US approval for its injectable antiplatelet drug Kengreal for the prevention of blood clots during heart procedures. ... TMC's chef executive Clive Meanwell said recently that the company believes cangrelor

AZ and Takeda drugs should carry heart failure warning

AZ and Takeda drugs should carry heart failure warning Cangrelor go-ahead. Meanwhile, the FDA's advisory committee also voted 9 to 2 in favour of approving The Medicines Company's injectable anticoagulant cangrelor as an adjunct to percutaneous coronary ... The FDA is due to deliver a final decision on

FDA reviewer backs approval of TMC's cangrelor

FDA reviewer backs approval of TMC's cangrelor Claims it offers a small benefit over Sanofi’s Plavix.  . The Medicines Company (TMC) looks on course finally to get approval for its intravenous antiplatelet drug cangrelor in the US after ... disease. . However, for TMC the delay in bringing

Antibiotics among 7 new drugs backed by EMA

Antibiotics among 7 new drugs backed by EMA The Medicines Company’s Orbactiv and Cubist’s Sivextro set for European approval. ... Other recommendations. The Medicines Company had a second new drug feature among the list of CHMP positive opinions.

FDA backs Cubist's antibiotic Zerbaxa

FDA backs Cubist's antibiotic Zerbaxa The ruling opened the door for generic competition to Cubicin in 2016 rather than 2018, which according to analysts could cost the company up to $2bn in lost sales. ... In addition to Sivextro, the agency also gave a green light this year to Durata

[ Previous 5 results ] 1 2 3 4 5 6 7 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Cegedim Health Data

Cegedim Health Data provides Real World Data and Evidence services to enable advancements in patient outcomes. With a data history...

Latest intelligence

The Patient Will See You Now – The Evolution of the Doctor-Patient Relationship
The doctor-patient relationship is an ever changing one that changes as society changes. Technology then helps to drive this change along with a wide number of other factors....
Mind the Gap – Challenging Immunisation Apathy and Misinformation
world, the biggest challenges remain apathy and misinformation. Since a measles vaccine was introduced in the UK in 1968, Public Health England estimates that 20 million measles cases and 4,500...
Towards Better HCP Engagement – An Email Masterclass
6% of HCPs prefer being contacted by email, compared to 17% who favour the second most popular option: direct interaction with reps....